2SEVENTY BIO, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.39 USD | -3.52% |
|
-12.40% | +2.58% |
| 08/05 | Earnings Flash (TSVT) 2SEVENTY BIO Reports Q1 Revenue $12.4M, vs. Street Est of $14.1M | MT |
| 08/05 | Transcript : 2seventy bio, Inc., Q1 2024 Earnings Call, May 08, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 23Cr | - | - | - | |||
| 6.26TCr | - | |||||
| 4.12TCr | ||||||
| 4.03TCr | ||||||
| 2.79TCr | ||||||
| 2.62TCr |
- Stock Market
- Equities
- TSVT Stock
- Charts 2seventy bio, Inc.
- Sector Chart
